Clinical Trials for Orca Bio

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Orca Bio

Clinical Trials (7)

NCT07216443
Reduced Intensity or Nonmyeloablative Conditioning With Orca-T for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
PHASE2Recruiting
80 participants
Started: Oct 7, 2025 · Completed: Dec 31, 2028
3 conditions1 sponsor4 locations
NCT06900192
A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis
PHASE1Not yet recruiting
10 participants
Started: Mar 31, 2025 · Completed: Aug 31, 2029
4 conditions2 sponsors0 locations
NCT05322850
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
PHASE1/PHASE2Recruiting
40 participants
Started: Aug 16, 2022 · Completed: Sep 30, 2027
7 conditions3 sponsors4 locations
NCT05316701
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
PHASE3Active, not recruiting
187 participants
Started: Jun 21, 2022 · Completed: Jul 31, 2026
7 conditions1 sponsor19 locations
NCT05088356
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
PHASE1Recruiting
60 participants
Started: Sep 7, 2021 · Completed: Dec 31, 2025
6 conditions2 sponsors1 location
NCT04013685
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
PHASE1Active, not recruiting
255 participants
Started: Nov 21, 2019 · Completed: Apr 30, 2027
6 conditions1 sponsor21 locations
NCT03802695
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
PHASE1Recruiting
300 participants
Started: Apr 8, 2019 · Completed: Dec 31, 2027
3 conditions1 sponsor8 locations